Advice Pharma Group
Advice Pharma Group is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
Efficacy and safety of a novel dual pH-dependent delayed-release ColeseveLam for the trEatment of bile Acid diarrhoea: a Randomized, double-blind, parallel-group, placebo-controlled clinical trial – CLEAR
Sponsor Monteresearch S.r.l.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2, Multi-center, Randomized, Dose-Ranging, Placebo-Controlled, Double-blind Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated - Acute Kidney Injury.
Sponsor River 2 Renal Corp.
- Start (EU)
- Latest update
- Estimated end
- Not reported
ExclUsive endocRine therapy Or radiation theraPy for women aged ≥70 years with luminal A-like early stage breast cancer (EUROPA): a randomized phase 3 trial
Sponsor University Of Florence
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicentre, prospective, open-label, non-comparative study to evaluate menstrual bleeding typology, tolerability, and compliance during a monophasic hormonal contraceptive treatment with norgestimate + ethinylestradiol in Italy.”
Sponsor Italfarmaco S.p.A.
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Effect of nepafenac/dexamethasone fixed dose combination vs. its individual components (nepafenac and dexamethasone monotherapies) on postoperative inflammation after cataract surgery: a randomized, multicentre, blinded-assessor, parallel-group clinical study – NE.DE.F. STUDY
Sponsor Medivis S.r.l.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Multi-Center, Open Label, Uncontrolled, Phase II Clinical Trial Evaluating the Safety and Efficacy of Venetoclax in Combination with Atezolizumab and Obinutuzumab in Richter Transformation of CLL
Sponsor ASST Grande Ospedale Metropolitano Niguarda
- Start (EU)
- Latest update
- Estimated end
Hormonal Receptor (HR)-positive HER2 negative breast cancer patients treated with preoperative ELacestrant and PULSAR adaptive radiotherapy: a phase II study
Sponsor Fondazione Radioterapia Oncologica Onlus
- Start (EU)
- Latest update
- Estimated end
- Not reported
"APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN".
Sponsor Fondazione Radioterapia Oncologica Onlus
- Start (EU)
- Latest update
- Estimated end
- Not reported
TOTAL NEOADJUVANT TREATMENT WITHOUT SURGERY FOR LOCALLY ADVANCED RECTAL CANCER: PROSPECTIVE CLINICAL TRIAL TO ASSESS TUMOR COMPLETE RESPONSE, CIRCULATING TUMOR GENETIC AND EPIGENETIC BIOMARKERS, AND STROMAL TRANSCRIPTOME TO INTERPRET CLINICAL OUTCOME (NO-CUT TRIAL)
Sponsor ASST Grande Ospedale Metropolitano Niguarda
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Advice Pharma Group?
The 2026-10-09 snapshot links Advice Pharma Group to 9 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Project management, Electronic data capture, among 19 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Advice Pharma Group?
The most frequently recorded therapeutic areas are Cardiology, Gastroenterology, Nephrology, Surgery and Perioperative Care. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Advice Pharma Group conducted?
The linked trials record locations in 2 countries, including Italy, Germany. These are trial locations, not confirmed office locations or countries where Advice Pharma Group delivered services.
What can this page tell me about Advice Pharma Group's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Advice Pharma Group. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Advice Pharma Group S.r.l.